CD8A and neoplasm: Dendritic cells (DCs) promoting the cross-presentation of tumor-associated antigens were considered paramount in antitumor immunity, and the effector activity of CD8+ T cells which were main effectors of anticancer immunity was dependent on DC-derived cytokines (Wculek et al., 2020).